Merck & Co. (MRK)
(Delayed Data from NYSE)
$110.71 USD
+0.39 (0.35%)
Updated Jun 9, 2023 04:03 PM ET
After-Market: $110.59 -0.12 (-0.11%) 4:42 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Balance Sheet
Fiscal Year End for Merck & Co, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 13,192 | 8,096 | 8,062 | 10,450 | 8,864 |
Receivables | 9,450 | 9,230 | 7,851 | 6,778 | 7,071 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 5,911 | 5,953 | 6,310 | 5,978 | 5,440 |
Other Current Assets | 7,169 | 6,987 | 5,541 | 4,277 | 4,500 |
Total Current Assets | 35,722 | 30,266 | 27,764 | 27,483 | 25,875 |
Net Property & Equipment | 21,422 | 19,279 | 17,986 | 15,053 | 13,291 |
Investments & Advances | 1,015 | 370 | 785 | 1,469 | 6,233 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 41,473 | 44,197 | 34,842 | 33,621 | 29,684 |
Deposits & Other Assets | 9,528 | 11,582 | 10,211 | 6,771 | 7,554 |
Total Assets | 109,160 | 105,694 | 91,588 | 84,397 | 82,637 |
Liabilities & Shareholders Equity | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 |
---|---|---|---|---|---|
Notes Payable | 1,946 | 2,412 | 6,431 | 3,610 | 5,308 |
Accounts Payable | 4,264 | 4,609 | 4,594 | 3,738 | 3,318 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 14,159 | 13,859 | 13,053 | 12,549 | 10,151 |
Income Taxes Payable | 1,986 | 1,224 | 1,575 | 736 | 1,971 |
Other Current Liabilities | 1,884 | 1,768 | 1,674 | 1,587 | 1,458 |
Total Current Liabilities | 24,239 | 23,872 | 27,327 | 22,220 | 22,206 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 1,795 | 3,441 | 1,015 | 1,470 | 1,702 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 28,745 | 30,690 | 25,360 | 22,736 | 19,806 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 8,323 | 9,434 | 12,482 | 11,970 | 12,041 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 63,102 | 67,437 | 66,184 | 58,396 | 55,755 |
Shareholders Equity | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1,788 | 1,788 | 1,788 | 1,788 | 1,788 |
Capital Surplus | 44,379 | 44,238 | 39,588 | 39,660 | 38,808 |
Retained Earnings | 61,081 | 53,696 | 47,362 | 46,602 | 42,579 |
Other Equity | -4,701 | -4,356 | -6,547 | -6,099 | -5,364 |
Treasury Stock | 56,489 | 57,109 | 56,787 | 55,950 | 50,929 |
Total Shareholder's Equity | 46,058 | 38,257 | 25,404 | 26,001 | 26,882 |
Total Liabilities & Shareholder's Equity | 109,160 | 105,694 | 91,588 | 84,397 | 82,637 |
Total Common Equity | 46,058 | 38,257 | 25,404 | 26,001 | 26,882 |
Shares Outstanding | 2,535.40 | 2,527.60 | 2,530.00 | 2,545.90 | 2,600.30 |
Book Value Per Share | 18.17 | 15.14 | 10.04 | 10.21 | 10.34 |
Fiscal Year End for Merck & Co, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 10,387 | 13,192 | 11,248 | 10,128 | 8,928 |
Receivables | 10,415 | 9,450 | 9,482 | 9,643 | 9,828 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 5,863 | 5,911 | 5,614 | 5,535 | 5,774 |
Other Current Assets | 6,737 | 7,169 | 7,217 | 6,810 | 6,654 |
Total Current Assets | 33,402 | 35,722 | 33,561 | 32,116 | 31,184 |
Net Property & Equipment | 21,758 | 21,422 | 20,424 | 20,059 | 19,747 |
Investments & Advances | 1,290 | 1,015 | 984 | 238 | 316 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 41,066 | 41,473 | 42,528 | 43,710 | 44,280 |
Deposits & Other Assets | 10,280 | 9,528 | 9,584 | 10,972 | 11,141 |
Total Assets | 107,796 | 109,160 | 107,081 | 107,095 | 106,668 |
Liabilities & Shareholders Equity | 3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 |
---|---|---|---|---|---|
Notes Payable | 2,672 | 1,946 | 1,936 | 2,979 | 1,208 |
Accounts Payable | 3,680 | 4,264 | 3,371 | 3,482 | 3,715 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 13,000 | 14,159 | 14,222 | 13,501 | 14,051 |
Income Taxes Payable | 1,872 | 1,986 | 1,698 | 1,438 | 1,571 |
Other Current Liabilities | 1,907 | 1,884 | 1,771 | 1,768 | 1,771 |
Total Current Liabilities | 23,131 | 24,239 | 22,998 | 23,168 | 22,316 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 1,442 | 1,795 | 2,417 | 2,974 | 3,071 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 28,074 | 28,745 | 28,482 | 28,684 | 30,586 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 8,244 | 8,660 | 8,951 | 9,742 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 60,891 | 63,102 | 62,557 | 63,777 | 65,715 |
Shareholders Equity | 3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1,788 | 1,788 | 1,788 | 1,788 | 1,788 |
Capital Surplus | 44,467 | 44,379 | 44,243 | 44,115 | 44,275 |
Retained Earnings | 62,039 | 61,081 | 59,928 | 58,437 | 56,252 |
Other Equity | -4,812 | -4,701 | -4,677 | -4,252 | -4,299 |
Treasury Stock | 56,577 | 56,489 | 56,758 | 56,770 | 57,063 |
Total Shareholder's Equity | 46,905 | 46,058 | 44,524 | 43,318 | 40,953 |
Total Liabilities & Shareholder's Equity | 107,796 | 109,160 | 107,081 | 107,095 | 106,668 |
Total Common Equity | 46,905 | 46,058 | 44,524 | 43,318 | 40,953 |
Shares Outstanding | 2,538.50 | 2,535.40 | 2,533.20 | 2,528.80 | 2,527.80 |
Book Value Per Share | 18.48 | 18.17 | 17.58 | 17.13 | 16.20 |